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Infections with HIV, hepatitis B virus, and hepatitis C virus can turn
into chronic infections, which currently affect more than 500 million
patients worldwide. It is generally thought that virus-mediated T-cell
exhaustion limits T-cell function, thus promoting chronic disease. Here
we demonstrate that natural killer (NK) cells have a negative impact
on the development of T-cell immunity by using the murine lympho-
cytic choriomeningitis virus. NK cell-deficient (Nfil3−/−, E4BP4−/−)mice
exhibited a higher virus-specific T-cell response. In addition, NK cell
depletion caused enhanced T-cell immunity in WT mice, which led to
rapid virus control and prevented chronic infection in lymphocytic
choriomeningitis virus clone 13- and reduced viral load in DOCILE-
infected animals. Further experiments showed that NKG2D triggered
regulatory NK cell functions, which were mediated by perforin, and
limited T-cell responses. Therefore, we identified an important role of
regulatory NK cells in limiting T-cell immunity during virus infection.
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Natural Killer (NK) cells are a subset of lymphocytes thatprovide innate effector mechanisms against viruses and tu-
mor cells through direct cytotoxic effects on target cells and
cytokine production (1). NK cells detect microbial insults by
Toll-like receptor stimulation or in response to proinflammatory
cytokines predominantly produced by dendritic cells (2, 3). No-
tably, type I interferons (IFN-I) are potent cytokines that trigger
NK cell activation during a viral infection (4). NK cells can also
sense microbial and nonmicrobial signals from target cells
through a variety of activating and inhibitory receptors. These
receptors influence the cytotoxicity toward virus-infected or
cancerous cells and may be involved in disease progression (5).
Activating receptors, such as NKG2D or Ly49H, are associated
with adaptor molecules that promote NK cell activation. Con-
versely, NK cell tolerance to self-tissue is maintained by inhibitory
receptors, such as Ly49a, which interact with self-MHC class I
(MHCI) molecules and prevent autoimmunity. However, MHCI-
independent inhibitory and stimulatory signals also contribute to
NK cell recognition, namely through NK cell receptor P1b (NKR-
P1b) and 2B4 (CD244), respectively (6–8).
NK cells play a vital role in limiting viral replication. Studies
have shown that NK cells are able to produce perforin, which is
responsible forNK cell-mediated cytotoxic effects (9). In addition,
NK cells can limit viral replication by binding to and sequestering
specific virus-encoded proteins. For example, activating receptor
Ly49H is able to engage the m157 viral glycoprotein encoded by
mouse CMV such that a deficiency in Ly49H leads to enhanced
mouse CMV replication (10). Moreover, the importance of
NK cells for viral clearance is underscored by the observation that
NK cell deficiencies in humans correlate with recurrent infections
with the varicella zoster virus and severe infections with herpes
simplex virus (11–13).
An immunoregulatory role for NK cells during virus infection
is also beginning to be elucidated. For example, antigen pre-
sentation is enhanced after NK cell depletion and infection with
lymphocytic choriomeningitis virus (LCMV) (14), supporting an
inhibitory role of NK cells on adaptive immunity. Furthermore,
NK cell depletion has also been reported to improve memory
T-cell formation (15). NK cells are able to produce interleukin
10 (IL-10) after activation, which was demonstrated to contrib-
ute to virus-mediated T-cell exhaustion (16, 17). Finally, a recent
report showed that the absence of the inhibitory receptor 2B4 on
NK cells resulted in a reduced virus-specific CD8+ T-cell re-
sponse that led to longer virus persistence (18).
The present study has identified a negative regulatory role for
NK cells during both an acute and a chronic virus infection. Our
data demonstrate that regulatory NK cells (NKreg) limit virus-
specific CD8+ T-cell immunity and promote chronic virus in-
fection or immune pathology. These studies establish a critical
negative role for NK cells in virus-induced immunity in vivo.
Results
NK Cells Show Enhanced Cytotoxicity During LCMV Infection. To
establish whether NK cell activity was induced after infection
with LCMV, we evaluated cytotoxic activity with YAC-1 target
cells, which are susceptible to NK cell-mediated lysis (19). After
coincubation with splenocytes from mice infected with LCMV
clone 13 or LCMV-Armstrong, NK cell cytotoxicity was ob-
served; these data are consistent with previous reports (4, 14).
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Acute LCMV infection with the Armstrong strain exhibited
lower cytotoxicity than that of clone 13, but both clearly induced
cytotoxicity compared with naïve controls (Fig. 1A). This cyto-
toxicity is mediated by perforin (9). Next, the surface expression
of activating and inhibitory receptors on NK cells was examined
after LCMV infection. Expression of the activating receptor
NKG2D was up-regulated on NK cells from WT mice after in-
fection with 2 × 106 pfu of LCMV strain WE (LCMV WE) (Fig.
1B). In contrast, expression of the inhibitory receptor 2B4 was
down-regulated in a proportion of NK cells after infection (Fig.
1C). Altogether, these data show that NK cells are strongly ac-
tivated after LCMV infection.
NK Cell Depletion Leads to an Enhanced CD8+ T-Cell Immune
Response. Given that 2B4 is an inhibitory receptor on NK cells
(18), we wanted to determine whether NK cells influenced the
CD8+ T-cell response during an infection with a high dose of
virus. To examine T-cell immunity in the absence of NK cells, we
used the NK1.1-depleting antibody (Fig. S1A) (20). Interestingly,
an increase in gp33-tetramer+ CD8+ T cells as well as np396-
tetramer+ CD8+ T cells was observed in NK cell-depleted mice
compared with LCMV-infected, NK cell-competent, mice (Fig.
2A). Consistently, IFN-γ production from LCMV-specific CD8+
T cells was significantly increased in the absence of NK cells
throughout the infection with LCMV (Fig. 2B and Fig. S1B).
Similar results were also seen when NK cell-depleted mice were
infected with 200 pfu of LCMV WE (Fig. 2C). Next, we adop-
tively transferred LCMV-specific transgenic T cells (P14) (21)
into control and NK cell-depleted mice at 1 d before infection
with 2 × 106 pfu of LCMV. After 3 d, we measured 30.3%
(±9.2%, P < 0.01, n = 7) more LCMV-specific CD8+ T cells in
NK cell-depleted mice compared with NK cell-competent mice.
Consistently, when we transferred negatively sorted T cells from
a P14+ animal (21) into control and NK1.1-treated animals
infected with 200 pfu of LCMV WE, we observed a larger P14
population in NK cell-depleted animals (Fig. 2D). Interestingly,
LCMV-specific T cells expressed more NKG2D ligands in




Fig. 1. NK cells are activated after LCMV infection. (A) Splenocytes from
naïve (Left), LCMV-Armstrong–infected (Center), and LCMV clone 13-infec-
ted (Right) mice were incubated with YAC-1 cells at the indicated effector/
target ratios. 51Cr release at different effector/target ratios is shown (n = 3,
mean ± SEM of duplicates). (B and C) NK1.1+CD3e− splenocytes were ana-
lyzed by flow cytometry for surface expression of NKG2D (B) and 2B4 (C) at
2 d after infection with 2 × 106 pfu of LCMV WE (n = 6; Student’s t test).
NKG2D expression (mean fluorescence intensity) (B) and 2B4 negative (%)






Fig. 2. NK cells limit CD8+ T-cell response in vivo and in vitro. WT and NK
cell-depleted mice were infected with 2 × 106 pfu of LCMV WE. (A) gp33-
specific (Left) and np396-specific (Right) tetramer response in the spleen (%
of CD8+ T cells) at the indicated time (days) after infection are shown (P <
0.01 for day 6 and P < 0.001 for day 8 gp33 tetramers; P < 0.001 for day 6 and
8 for np396 tetramers; two-way ANOVA, n = 6 of two independent experi-
ments). (B) IFN-γ+CD8+ of all CD8+ splenocytes are shown after restimulation
with gp33 (Left) or np396 (Right) peptide (P < 0.001 for days 6 and 8 post-
infection, two-way ANOVA, n = 6). (C) Control or NK cell-depleted mice were
infected with 200 pfu of LCMV WE. At 8 d postinfection, splenocytes were
restimulated with the LCMV-specific epitope gp33, and IFN-γ production was
determined (n = 7–8; two-way ANOVA). (D) A total of 2 × 106 negatively
sorted, CD45.1+ P14 T cells were transferred at 2 d postinfection with 200 pfu
of LCMV WE into control and NK cell-depleted mice. CD45.1+CD8+ pop-
ulation was analyzed (Left; n = 6; P < 0.05 for aNK1.1 from naïve and control
group using one-way ANOVA), and NKG2D–hIgG expression was measured
(one representative of n = 3–6 is shown). (E) Negatively sorted T cells were
activated with anti-CD3/CD28 antibodies and coincubated with purified NK
cells from naïve or LCMV-infected mice (day 2, 2 × 106 pfu) or naïve NK cells
stimulated with IFN-α4. CD8+ T-cell number was compared after 72 h (n = 3–
4; *P < 0.05, one-way ANOVA). (F) Nfil3−/− and nfil3+/− mice were infected
with 2 × 105 pfu of LCMV WE. At 6 d after infection, splenocytes were
restimulated in vitro with the virus-specific peptides gp33 and np396, and
IFN-γ production was determined by intracellular cytokine staining and FCM
analysis (n = 5–6 of two independent experiments; P < 0.01 for gp33 and
np396, two-way ANOVA). (G) WT or NK cell-depleted mice were infected
with 2 × 106 pfu of LCMV clone 13. Splenocytes from control or NK cell-
depleted mice were restimulated ex vivo with the virus-derived peptides
gp33 and np396 at 10 d after infection. Intracellular production of IFN-γ by
CD8+ T cells was measured by FCM analysis (n = 6 of two independent
experiments; P < 0.001 for gp33 and np396, two-way ANOVA).









that LCMV-induced T-cell activation induces expression of
NKG2D ligands on T cells. In NK cell-depleted mice, NKG2D
ligand expression did not differ from control mice (Fig. 2D).
To evaluate whether NK cells could modulate effector T-cell
function, we coincubated purified NK cells from naïve and
LCMV-infected mice with in vitro-activated T cells. Indeed, NK
cells from infected animals could limit T-cell expansion, as evi-
denced by the reduction in the number of T cells when LCMV-
activated NK cells were present (Fig. 2E). Because NK cells can
be activated by IFN-I after viral infection (4), we wanted to
determine whether the presence of IFN-α4 could trigger NK cell-
mediated inhibition of T-cell expansion. To this end, we cocul-
tured naïve NK cells with IFN-α4 and observed a similar re-
duction in the T-cell population (Fig. 2E). Nfil3−/− (E4bp4−/−)
mice, which have a severe paucity of NK cells but normal pro-
portion of NKT cells (22, 23), were also examined to further
evaluate the impact of NK cells in LCMV-induced T-cell im-
munity. Consistent with our findings, Nfil3−/− mice displayed
significantly enhanced IFN-γ production after LCMV infection
(Fig. 2F). Altogether, these data suggest that the presence of NK
cells limits the expansion of T cells in vitro and in vivo.
Because the presence of NK cells has a negative impact on
CD8+ T-cell function, we examined whether NK cells play a role
in establishing chronic viral infections. NK cell-depleted and NK
cell-competent mice were infected with LCMV clone 13, and the
function of virus-specific T cells was examined at 10 d after in-
fection. Strikingly, virus-induced cytokine production was not
exhausted in NK cell-depleted animals (Fig. 2G). Therefore, NK
cells were able to limit the expansion of virus-specific T cells
during both acute and chronic infection.
NKG2D Triggers Regulatory Functions of NK Cells. Because NK cells
exhibited higher NKG2D expression and virus-specific T cells
consistently showed enhanced expression of NKG2D ligands after
infection, we next addressed whether NKG2D triggers regulatory
functions of NK cells. First, we treated one group of mice with
a NKG2D-blocking antibody (clone CX5) (24, 25) and a second
group of control animals with an isotype control. When nega-
tively sorted, 5,6-carboxyfluorescein diacetate succinimidyl ester
(CFSE)-labeled P14+ T cells were transferred into both groups,
we observed an increased protortion of P14 cells in anti–NKG2D-
treated animals compared with control mice (Fig. 3A). Next we
wanted to determine whether NKG2D blockade could improve
endogenous T-cell immunity during infection with 2 × 106 pfu of
LCMV WE. Consistently, more gp33-tetramer+CD8+ T cells
were detected in anti–NKG2D-treated animals at 8 d after in-
fection (Fig. 3B). In addition, a larger population of CD8+ T cells
from anti–NKG2D-injected mice was able to produce IFN-γ after
restimulation with the LCMV-specific peptides gp33 and np396
compared with control animals (Fig. 3C). Altogether, these data
support a critical role of NKG2D in limiting T-cell immunity.
NK Cells Limit T-Cell Immunity by Perforin Production. Previous
studies have shown that cytotoxic function of NK cells can be
mediated via NKG2D (26–29) and perforin (9). Experiments were
done to determine whether NK cells from virus-infected mice
limited CD8+ T cell function via a perforin-dependent mechanism.
Because perforin is a major effector molecule of CD8+ T cells, we
provided functional T cells to WT and perforin−/− mice by trans-
ferring 5 × 104 splenocytes from congenically marked (CD45.1+)
P14 transgenic mice (21). Interestingly, virus-mediated IFN-γ
production of CD8+ T cells was enhanced in single-cell suspen-
sions from perforin−/− spleen and liver tissue after restimulation
with the LCMV-specific epitope gp33 (Fig. 4A). Accordingly, after
A
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Fig. 3. NKG2D triggers NKreg functions. (A) Mice were treated with NKG2D-
blocking antibody or isotype control (day −1, day 2 postinfection) and
infected with 200 pfu of LCMV WE (day 0). On day 2, 2 × 106 negatively
sorted, CFSE-labeled, and congenically marked P14 T cells were transferred
into animals of both groups. On day 4 after infection, CFSE expression and
expansion of CD45.1+CD8+ cells were determined (n = 3–4; Student’s t test).
(B and C) Mice were treated with NKG2D-blocking antibody or an isotype
control (day −1, 12 h postinfection) and infected with 2 × 106 pfu of LCMV
WE. gp33-tetramer+ was measured at 8 d after infection (n = 3; Student’s t
test) (B), and IFN-γ production was determined after restimulation with the




Fig. 4. NK cell-mediated perforin production limits T-cell immunity. (A and
B) Splenocytes (50,000) from P14+CD45.1+ mice were transferred into per-
forin−/− and WT mice and infected with 2 × 106 pfu of LCMV WE. (A) At 8 d
postinfection, IFN-γ production of CD8+ T cells after restimulation with gp33
was determined in single-cell suspensions of spleen and liver tissue (n = 6; P <
0.01, Student’s t test). (B) One group was treated with an NK cell-depleting
antibody, and IFN-γ production was monitored (n = 5–6; *P < 0.05 for aNK1.1,
perforin−/−, and aNK1.1 perforin−/− vs. control, Newman–Keuls one-way
ANOVA). (C) A total of 2 × 106 negatively sorted, CFSE-labeled T cells from
P14+CD45.1+ mice were transferred into WT and perforin−/− mice on day 2
postinfection with 200 pfu of LCMV WE. (Left) After 48 h, CFSE expression of
the CD45.1+CD8+ population was analyzed. (Right) Relative amount (%) of
CD45.1+CD8+ cells in perforin−/−mice compared withWTmice (n = 4; P < 0.01,
Student’s t test).
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NK cell depletion, perforin−/− mice exhibited similar virus-induced
IFN-γ production (Fig. 4B). To determine whether NK cell-me-
diated perforin production affected T-cell proliferation, we trans-
ferred 2 × 106 negatively sorted, CFSE-labeled P14 CD8+ T cells
into perforin−/− andWTmice. Consistent with the data on NK cell-
depleted and anti–NKG2D-treated mice, an increased number of
P14 cells was observed in perforin−/− animals (Fig. 4C). Altogether,
these data suggest that perforin-mediated NK cell cytotoxicity
affects virus-specific CD8+ T-cell immunity.
NK Cells Influence Chronic Viral Infection and Virus-Induced Immuno-
pathology. To investigate the impact of NK cells on LCMV in-
fection, we first analyzed whether NK cells affected virus repli-
cation. At 4 d after infection, NK cell-depleted mice showed
similar virus titers and virus distribution in liver and spleen tissue
(Fig. S2 A and B) and had comparable IFN-I levels in the serum
to those in control animals (Fig. S2C). IFN-I–regulated genes
were also efficiently up-regulated in control and NK cell-de-
pleted animals (Fig. S2D), suggesting that NK cells did not
directly act on virus replication.
Because CD8+ T-cell immunity is crucial for LCMV clearance
(30, 31), we hypothesized that NK cells might promote chronic
infection by limiting CD8+ T-cell function. LCMV clone 13 and
LCMV DOCILE establish chronic virus infections resulting in
T-cell exhaustion followed by virus persistence (32, 33). Because
we observed enhanced T-cell immunity in the absence of NK cells,
we wanted to investigate whether NK cell depletion could prevent
viral persistence. When we measured virus titers at 10 d after
infection with LCMV clone 13, animals depleted of NK cells
exhibited diminished viral titers compared with control mice in all
compartments analyzed (Fig. 5A). Infections with a high dose of
LCMV DOCILE showed that NK cell-depleted mice were also
able to eliminate the virus from spleen and liver tissue (Fig. 5B),
and they exhibited reduced titers in kidney and lung tissue (Fig.
S3A). Importantly, these data demonstrate that the presence of
NK cells has the ability to promote chronic viral infections.
Next, we wanted to determine whether NK cells could affect
virus-induced hepatitis, which was previously reported in mice
infected with 2 × 106 pfu of LCMV WE (30, 31). Indeed, virus
titers in the liver were reduced in mice depleted of NK cells (Fig.
5C). Consistently, LCMV WE was eliminated rapidly in the ab-
sence of NK cells in the spleen, lung, and kidney (Fig. S3B andC).
Accordingly, immunohistology revealed that the number of
infected cells was highly reduced in liver (Fig. 5D) and spleen (Fig.
S3D) tissue of NK cell-depleted mice, whereas LCMV was still
readily observed in control mice (Fig. 5D and Fig. S3D). Impor-
tantly, NK cell-depleted mice showed reduced virus-dependent






Fig. 5. NK cells promote development of chronic infection and immunopathology. (A) WT or NK cell-depleted mice were infected with 2 × 106 pfu of LCMV
clone 13. Virus titers were determined from spleen, liver, kidney, and lung tissue at 10 d after infection [n = 8 of two independent experiments; P < 0.001
except liver (P < 0.05) of 10log(Titer), Student’s t test]. (B) Control and NK cell-depleted mice were infected with 10
5 pfu of LCMV DOCILE. Virus titers were
measured after 33 d (n = 5, Student’s t test). (C–E) WT or NK cell-depleted mice were infected with 2 × 106 pfu of LCMV WE. (C) At 6 and 8 d postinfection,
virus titers were analyzed in spleen tissue. (n = 6). *P < 0.05, significant difference for 10log(Titer), Student’s t test. (D) Liver from control and NK cell-depleted
mice were analyzed for LCMV nucleoprotein expression by immunohistology. One representative picture is shown (n = 5). (E) WT mice or NK cell-depleted
mice were infected with 2 × 106 pfu of LCMV. Hepatitis induction was assessed by measuring ALT activity in the sera at different time points (n = 2–11; P < 0.05
for day 10 and P < 0.01 for day 12 postinfection, two-way ANOVA). (F) Nfil3−/− and nfil3+/− mice were infected with 2 × 105 pfu of LCMV WE. ALT activity in
the serum of nfil3−/− and nfil3+/− mice was determined at 11 d postinfection (n = 7–8; P < 0.01 using Student’s t test).









activity in the sera (Fig. 5E). In addition, Nfil3−/− mice exhibited
reduced ALT activity in the serum (Fig. 5F). In conclusion, these
data demonstrate that the presence of NK cells promotes immuno-
pathology, including viral persistence and virus-induced hepatitis.
Discussion
Our study examined the regulatory function of NK cells in an-
tiviral response to a noncytopathic murine virus, LCMV. NK cell
depletion promoted virus-induced CD8+ T-cell immunity, which
led to rapid viral clearance. We demonstrated that infection with
LCMV clone 13 or LCMV DOCILE, which normally establishes
a chronic infection, was cleared within 10 d in the absence of NK
cells. Consistent with this finding, virus-induced immunopatholo-
gies were also abolished in NK cell-deficient mice because the
improved CD8+ T-cell response eliminated LCMV in the liver.
Mechanistically, NKreg functions were activated by NKG2D, which
may have triggered perforin-mediated killing of T cells.
Although it is well established that NK cells produce IL-10
(16), the involvement of NKG2D-mediated perforin production
remains unclear. Our data show that NKG2D expression by NK
cells increased during infection with LCMV and that NKG2D
blockade enhanced T-cell immunity. It is likely that NKreg
functions are mediated by perforin because perforin−/− mice
exhibited an enhanced antiviral T-cell response. Previous studies
have shown that perforin−/−mice succumb to infection of even low-
dose infection with LCMV because of increased IFN-γ production
(9, 34). By limiting T-cell immunity, NK cell activation may pro-
vide an evolutionary advantage by preventing excessive immuno-
pathology. In our setting, however, NK cell depletion led to highly
increased T-cell immunity followed by virus elimination and an-
tigen control. Thus, perforin-mediated regulatory functions might
be critical to preventing lethal immunopathology or autoimmunity
under some circumstances.
Our data add to the existing evidence that NK cells provide
immunoregulatory functions during chronic virus infections.
Infections with hepatitis B virus, hepatitis C virus (HCV), and
HIV often lead to chronic infections. The involvement of NK
cells during these virus infections has been discussed but poorly
understood (35–37). Data generated from patient studies sup-
port a regulatory role of NK cells during chronic infections.
These reports have shown that NK cells are activated in patients
suffering from chronic infection with HCV (38, 39). However,
HCV does not interfere with NK cell activity in vitro (38). In
humans, the killer cell Ig-like receptors (KIRs) represent a di-
verse family of activating and inhibitory receptors that bind to
the MHCI ligands. The KIR haplotypes vary in type and number
of genes. Interestingly, the homozygous expression of the in-
hibitory NK cell receptor gene KIR2DL3 and its ligands, the
HLA-C group 1 alleles, correlate with clearance of HCV (40). In
turn, the activating receptor gene KIR2DS3 is associated with
elevated transaminases and seropositive HCV infection (41).
Both studies suggest that reduced NK cell activity might have
a beneficial impact on HCV clearance. Recent evidence also
suggest that NK cell activity induced during chronic HCV in-
fection contributes to liver injury through cytotoxicity, although
changes in IFN-γ production were not detected (39). In light of
our findings, NK cells could limit virus-specific T-cell immunity
in chronically infected patients and thus trigger higher viral load
and enhanced immunopathology.
Our conclusion, that NK cells may enhance the immunopa-
thology associated with chronic virus infection, brings an in-
teresting aspect to hepatitis virus therapy. A recent report
demonstrated that the amount of degranulated NK cells corre-
lates with ALT elevation in HCV-infected patients (39). More-
over, a previous report showed that IFN-αs can not only inhibit
virus replication but also activate NK cells (4). Our in vitro data
showed that IFN-α was able to activate NKreg functions, which
resulted in limited T-cell expansion. Thus, IFN-α therapy might
suppress the virus-specific CD8+ T-cell response as long as NK
cells are present. However, a therapeutic regimen that combines
IFN-α and NK cell depletion or NKG2D blockage might be
much more powerful in eliminating hepatitis viruses.
Materials and Methods
Mice, Viruses, and Virus Titration. LCMV WE was originally obtained from
F. Lehmann-Grube (Heinrich Pette Institute, Hamburg, Germany) and was
propagated in L929 cells as described (42). LCMV clone 13 (a generous gift
from Sam Basta, Queens University, Kingston, ON, Canada) and LCMV-
Armstrong (a generous gift from Rolf Zinkernagel (University of Zurich,
Zurich, Switzerland) was grown in L929 cells (32, 43). Virus titers were
measured with a plaque-forming assay as described (44). Mice were infected
i.v. with 2 × 106 pfu of LCMV WE or LCMV clone 13 or 105 pfu of LCMV
DOCILE. Acute infections were established by infecting mice with 200 pfu of
LCMV WE. All mice used in this study were maintained on the C57BL/6 ge-
netic background. All experiments were performed in single ventilated
cages. Animal experiments were carried out in accordance with the guide-
lines of the Ontario Cancer Institute and the German law for animal pro-
tection. Nfil3−/− mice and P14 T-cell receptor transgenic mice have been
previously described (21, 23). NK cells were depleted with i.v. injection of anti-
NK1.1 [clone PK136, kindly provided by Yonghong Wan (McMaster Univer-
sity, Hamilton, ON, Canada) and purchased with corresponding isotype con-
trol at BD Pharmingen] antibody at 3 d and 1 d before infection (0.2 mg per
mouse) (Fig. S1A) (20). Anti-NKG2D antibody (clone CX5) and corresponding
isotype control (eBioscience) was given on day −1 and 2 d after infection with
200 pfu and day −1 and 12 h after infection with 2 × 106 pfu of LCMV WE.
NK Cell Cytotoxicity Assay. Details of the NK cell cytotoxicity assay are de-
scribed in SI Materials and Methods.
IFN Production. IFN-α ELISA was performed according to the manufacturer’s
instructions (PBL).
Purification of T Cells and NK Cells. For T-cell and NK cell purification, single-
cell suspended splenocytes were enriched following the manufacturer’s
instructions (pan T-cell MACS kit, NK cell MACS kit; Miltenyi).
T-Cell Proliferation. T-cell proliferation is described in SI Materials and Methods.
ALT serum levels were measured with a serum multiple biochemical an-
alyzer (Ektachem DTSCII; Johnson & Johnson Inc.).
Quantitative RT-PCR Measurement. RT-PCR analysis was performed as pre-
viously described (45). Detailed procedures are described in SI Materials
and Methods.
Histology. Histological analysis was performed on snap-frozen tissue as de-
scribed (46). Antibodies against mouse CD8 (clone YTS169.4) and LCMV NP
(clone VL4) were used. A color reaction was developed with an alkaline
phosphatase system.
Flow Cytometry (FCM) Analysis. Tetramer was provided by the National
Institutes of Health (NIH) Tetramer Core Facility at the Emory University.
Tetramer, surface, and intracellular FCM staining were performed as de-
scribed previously (45). NKG2D–human IgG (hIgG) was used to indicate
NKG2D ligand expression (47). Detailed procedures are described in SI
Materials and Methods.
Gradient Centrifugation. Detailed gradient centrifugation procedures (48) are
described in SI Materials and Methods.
Statistical Analysis. Data are expressed as mean ± SEM. Statistically significant
differences between two different groups were analyzed with Student’s t
test. Statistical difference between several groups was tested with one-way
ANOVA with additional Bonferroni, Newman–Keuls, or Dunnett’s test. Sta-
tistically significant differences between groups in experiments involving more
than one analysis time point were calculated with two-way ANOVA (repeated
measurements). P < 0.05 was considered to be statistically significant.
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